Target Profile
```
Patient's age must be greater than or equal to 18 years.
Patient must have active diagnosis of HER2-positive carcinoma of breast.
Patient must have active diagnosis of Metastasis from malignant tumor of breast.
Patient must have a health evaluation score of ECOG performance status grade:Prid:Pt:^Patient:Nom:Observed less than or equal to 2.
Patient must not have most recent measurement of Left ventricular Ejection fraction greater than or equal to 50 %.
Patient must not have drug allergy to ingredient trastuzumab.
Patient must not have active diagnosis of Hepatic failure.
Patient must not have active diagnosis of Hepatitis A.
Patient must not have active diagnosis of Hepatitis B.
Patient must not have active diagnosis of Viral hepatitis C.
Patient must not have historical diagnosis of Congestive heart failure AND New York Heart Association Classification - Class II.
Patient must not have historical diagnosis of Congestive heart failure AND New York Heart Association Classification - Class III.
Patient must not have historical diagnosis of Congestive heart failure AND New York Heart Association Classification - Class IV.
Patient must not have historical diagnosis of Heart attack within less than or equal to 6 months.
Patient must not have historical diagnosis of Unstable angina within less than or equal to 6 months.
Patient must not be pregnant.
Patient must not be breastfeeding.
Patient must not have historical diagnosis of HIV infection.
Patient must not have adverse event of Grade 2 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 3 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 4 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 5 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 2 Peripheral motor neuropathy.
Patient must not have adverse event of Grade 3 Peripheral motor neuropathy.
Patient must not have adverse event of Grade 4 Peripheral motor neuropathy.
Patient must not have adverse event of Grade 5 Peripheral motor neuropathy.
Patient must not have adverse event of Grade 2 Encephalopathy.
Patient must not have adverse event of Grade 3 Encephalopathy.
Patient must not have adverse event of Grade 4 Encephalopathy.
Patient must not have adverse event of Grade 5 Encephalopathy.
```
